Advertise | About Us | Contact Us

Article - Issue 63

Rethinking Inflammation

Article - Issue 63

Beyond Trial and Error

Article - Issue 63

Reimagining Pharmacovigilance

Article - Issue 63

FROM ALGORITHMS TO BIOLOGY

Article - Issue 63

Beyond Human Intuition

EDITORIAL SECTIONS

Why X-ray Inspection is a Viable Quality Assurance Solution for Pharma Products

Adopting the Power of AI to Drug Development Projects

A tremendous amount of documentation is created throughout the clinical trial lifecycle

Real-world Evidence

Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA

Just in Time Manufacturing Creating more sustainable supply chains

Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine

Challenges and Advantages of Using Artificial Intelligence in Pharma

Many advanced largescale AI initiatives still need to be proved successful in Pharma

Advisory Board

Victor M. Diaz Perez

Brian D Smith

Nigel Cryer FRSC

Quang Bui

Tamara Miller

Imedla Leslie Rillon

Andri Kusandri

Nicoleta Grecu

Alessio Piccoli

Pramod Kashid

Neil J Campbell

Thomson Reuters

Senior Vice President
We believe publications such as Pharmafocus Asia are essential in providing professionals with insights into the dynamic and evolving trends of the Pharma industry

Why tier-2 and tier-3 cities are not included for clinical research

India is rapidly emerging as a global hub for clinical research with many international pharmaceutical companies and research organisations choosing the country as a site for their clinical trials

Review On Potential Phytocompounds In Drug Development For Parkinson Disease: A Pharmacoinformatic Approach

Abstract Parkinsons disease PD is caused by human physiological function and is ranked as the second most common neurodegenerative disorder One of the prominent therapies currently available for PD is the use of dopamine agonists which mimic the natural action of dopamine in the brain and stimulate dopamine receptors directly Currently available pha

Case Studies

Heat Stable Hepatitis B vaccine

Partner Since Arecor has collaborated with PATH an international global health nonprofit organisation on the development of heat stable vaccines using the ArestatT technology Stabilisation of hepatitis B vaccine one of the many vaccines successfully st

Techno Trends

Susvimo™, Breakthrough Therapy Discovered for Wet Age-Related Macular Degeneration (nAMD)

Roche discovered breakthrough therapy Susvimo ranibizumab injection for the treatment of people with neovascular or wet agerelated macular degeneration nAMD Susvimoearlier known as port delivery system with ranibizumab is the first and only alternative treatment in years which provides standardofcare

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

Smart Polymeric Nanocomposites for Cancer Therapeutics

Saurabh Shivalkar

Saurabh Shivalkar is a research fellow at Department of Applied Sciences, IIIT Allahabad, India. He did his M. Tech (Biomedical Engineering) from IIIT Allahabad. He has recently filed patent and published multiple papers in the allied areas of biomedical engineering and nanobiotechnology.

Sneha Ranjan

Sneha Ranjan is currently pursuing M.Sc. (Biotechnology) at Department of Biotechnology of Babasaheb Bhimrao Ambedkar University, Lucknow. She has worked on projects such as purification and characterisation of enzyme, production of recombinant proteins for diagnostics and therapeutics. She is currently working on polymeric nanocomposites for cancer therapeutics.

The Growing Role of Biocatalysis in Industrial Synthesis

Dr Reuben Carr

Dr Reuben Carr has over 25 years of experience in developing proprietary biocatalytic processes for fine chemical and pharmaceutical manufacturing. He specialises in using directed evolution to engineer natural enzymes to carry out novel chemical reactions, enabling the synthesis of challenging molecular targets for clients and customers.

Demystifying Lead-time bias and Length-time bias in Clinical Trials

Jefry Winner G

Jefry Winner G has completed his MBBS from Vinayaka Missions Medical College. He is currently pursuing a Doctorate of Medicine in Pharmacology at JIPMER Puducherry. He is interested in clinical research and is currently involved in an academic clinical trial involving Epilepsy. He has four years of clinical experience in healthcare and Academia. His area of interest includes Clinical trials, Pharmacotherapeutics, Drug safety, and clinical pharmacology. He also has over 15 publications in peer-reviewed journals.

Data-Enriched Edible Pharmaceuticals (DEEP) as Patient-Tailored Drug Products

Natalja Genina

Natalja Genina, Associate professor at University of Copenhagen (UCPH), Denmark. Her research interest include fabrication of advanced drug delivery systems and their integration into digital health. Dr. Genina has a remarkable publication record in her research field.

Jukka Rantanen

Professor, UCPH

Johan Bøtker

Associate Professor, UCPH

Sofia Kalvemark Sporrong

Sofia Kälvemark Sporrong, Professor at Uppsala University, Sweden. Expert in social pharmacy. Kälvemark Sporrong is a social scientist doing research within the area of pharmaceuticals. Her research interests include the patient perspective on drug use, pharmaceutical policy and professional ethics for health care staff.

When Orphan Drugs Make All the Difference

Sue Lee

Sue Lee has worked for World Courier for 25 years. During this time she has experienced a variety of customer service and operational functions, including the setting up of numerous, multi-national, clinical sites for the transportation of biological samples. She orchestrated the shipping of thousands of shipments with very specific temperature requirements to a host of challenging locations, and each presenting their own obstacles and dilemmas.

INDUSTRY UPDATES

press releasesRead more...

Transcenta Therapeutics and WuXi Biologics Enter into Strategic Collaboration to Accelerate Commercialization of HiCB Continuous Bioprocessing Technologies

Transcenta Therapeutics HKEX a global clinicalstage biopharmaceutical company with fully integrated capabilities in discovery RD and process development of antibodybased therapeutics

1cBio and Lee's Pharmaceutical Holdings Limited Enter into Exclusive Licensing Agreement to Develop and Commercialize 1cBio's PARP1 Inhibitor OC-3 for Oncology in Greater China

cBio a biopharmaceutical company focused on discovering and developing innovative therapies for serious and underserved conditions including oncology and metabolic diseases and Lees Pharmaceutical

BrYet Announces AIFA Approval of First-In-Kind cGMP Manufacturing Line for ML-016, Enabling Imminent Clinical Supply to Australia

BrYet US Inc BrYet a biotechnology innovator focused on developing potentially curative therapies for advanced cancers today announced AIFA approval of a firstinkind cGMP manufacturing line

University News University of New Haven Expands Industry Partnerships, Creates New Collaborations with Four Technology-Driven Companies

The University of New Haven announced today the execution of Master Partnership Agreements with four leading companies Sailion Medtronic Sheffield Pharmaceuticals and ARBURG

Sanofi and Keke Palmer team up to urge parents to help protect babies from serious RSV with BEYFORTUS®

Sanofi is partnering with Emmy Awardwinning actress entrepreneur and mom Keke Palmer to help educate families about the importance of protection against serious RSV lung infection for babies

Approval for Cefiderocol in Australia

Shionogi Co Ltd announced today that it has received marketing authorization from the Therapeutic Goods Administration TGA in Australia for cefiderocol a siderophore cephalosporin developed by Shionogi for the treatment of carbapenemresistant Gramnegative bacterial infections This marketing auth...